This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Epidermal keratinocytes produce high levels of interferon-β during skin injury and psoriasis through MAVS signaling activated by the antimicrobial peptide LL37 and double-stranded RNA from necrotic cells. This MAVS-dependent pathway triggers the TBK1-AKT-IRF3 cascade, promoting interferon-β production and dendritic cell maturation.
Why it matters
Understanding how keratinocytes produce interferon-β via LL37 and MAVS reveals key mechanisms driving skin inflammation in diseases like psoriasis and wound healing. This knowledge could guide development of targeted therapies to control harmful skin inflammation.
How the study worked
The study used human psoriatic and wounded skin samples and mouse models to investigate interferon-β production by keratinocytes. Molecular analyses identified the role of LL37, MAVS, and downstream signaling components in activating interferon-β expression and immune responses.
What this study cannot tell us
The study does not specify the exact study type or provide detailed quantitative data on sample sizes, limiting assessment of evidence strength. Further research is needed to confirm findings in larger cohorts and clinical settings.
Read the original research
Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.
Immunity, 45(1), 119-30
Citation
Zhang, Ling-Juan; Sen, George L; Ward, Nicole L; Johnston, Andrew; Chun, Kimberly; Chen, Yifang; Adase, Christopher; Sanford, James A; Gao, Nina; Chensee, Melanie; Sato, Emi; Fritz, Yi; Baliwag, Jaymie; Williams, Michael R; Hata, Tissa; Gallo, Richard L. (2016). Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.. Immunity, 45(1), 119-30. https://doi.org/10.1016/j.immuni.2016.06.021